SCHEMBL5205623

SCHEMBL5205623

COc1ccc(C2(C(N)=O)CCCC2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.65
CYP3A4 P08684 1/20 0.57
CYP2C19 P33261 1/20 0.57
KDM4E B2RXH2 4/20 0.55
ALDH1A1 P00352 3/20 0.55
MAPT P10636 2/20 0.55
MAPK1 P28482 1/20 0.55
GAA P10253 1/20 0.51
KMT2A Q03164 4/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CHRM2 P08172 1/20 0.49
CHRM1 P11229 1/20 0.49
SLC6A4 P31645 1/20 0.49
SLC6A3 Q01959 1/20 0.49
CYP2C9 P11712 1/20 0.48
MEN1 O00255 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2112323 0.98 LMNA (0.68) LMNACYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL10002472 0.97 LMNA (0.60) LMNACYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL1480336 0.93 LMNA (0.55) LMNACYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL2701584 0.85 ALDH1A1 (0.59) LMNACYP3A4CYP2C19ALDH1A1MAPT
SCHEMBL7293343 0.85 ALDH1A1 (0.80) LMNACYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL13692378 0.84 CYP3A4 (0.58) LMNACYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL503291 0.84 KMT2A (0.65) LMNACYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL21874269 0.83 KMT2A (0.63) LMNACYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL8586765 0.83 KDM4E (0.58) LMNACYP3A4CYP2C19KDM4EALDH1A1
SCHEMBL15256583 0.83 CYP3A4 (0.57) LMNACYP3A4CYP2C19KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP claimed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP claimed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO claimed